Introduction
============

Brain arteriovenous malformations (BAVMs) comprise tangles of abnormally developed arteries and veins without intervening capillaries.^[@B1]^ As a consequence, an abnormal shunting of arteries and veins occurs and results in high-pressure vascular channels that are at a risk of rupturing, often with catastrophic results.^[@B2]^ Therefore, appropriate management is necessary to reduce lifetime risk of morbidity and mortality of BAVMs.

The BAVMs always provide challenge for neurosurgeons, as the risk of procedure may outweigh the benefits.^[@B3]^ Spetzler-Martin grading has been widely used for determining surgical-related morbidity,^[@B4]^ subsequently Lawton et al.^[@B5]^ proposed supplementary grading for determining surgical morbidity of BAVMs. However, high risk patients such as history of hemorrhage,^[@B6]--[@B8]^ young age,^[@B9],[@B10]^ deep venous drainage,^[@B6],[@B11],[@B12]^ and female^[@B10]^ might need more aggressive modalities due to lifetime risk of hemorrhage. Despite high risk patients are well-identified, direct pathological evidences about the differences that are possessed by high risk patients are still lacking.

The aim of this study is to investigate the histopathological evidences of BAVMs features in association with identified risk factors for subsequent hemorrhage in Japanese patients.

Materials and Methods
=====================

I.. Patient population
----------------------

A total of 54 specimens were obtained from the surgical treatment of BAVMs of Japanese patients at Kyoto University Hospital with standard indications. Clinical data of the patients are summarized in [Table 1](#T1){ref-type="table"}.

II.. Sample preparation
-----------------------

All specimens were fixed in 10% formalin overnight and embedded in paraffin the next day. The specimens were stored at room temperature. Specimens were sliced into multiple and sequential 6-μm thick sections, deparaffinized in xylene, rehydrated, and then used for histological studies. All specimens were stained with hematoxylin-eosin and observed with a BX51 microscope (Olympus Optical Co., Ltd., Tokyo).

III.. Assessment of infiltrating cells
--------------------------------------

We searched the focus of inflammation in the nidus by using low power magnification. Then, the number of infiltrating cells was observed by using high power magnification on three adjacent fields. The average numbers of infiltrating cells were classified semi-quantitatively as follows: less than 20 (mild), 20--40 (moderate), and more than 40 (severe).

IV.. Assessment of intimal hyperplasia
--------------------------------------

The thickest tunica intima of the vein in hematoxylin-eosin stained samples was recorded. The findings were classified semi-quantitatively as follows: less than 100 μm (mild), 100--200 μm (moderate), and more than 200 μm (severe).

V.. Assessment of microvessel accumulation
------------------------------------------

Initially, we identified the highest vascular density region in the nidus of the hematoxylin-eosin stained samples by using low power magnification, then measured the number of microvessels (\< 100 μm) by using high power magnification (10× objective). The findings were classified semi-quantitatively as follows: less than 10 (mild), 10--20 (moderate), and more than 20 (severe).

VI.. Assessment of venous enlargement
-------------------------------------

We carefully determined the largest venous diameter in hematoxylin-eosin stained samples. The findings were classified semi-quantitatively as follows: less than 1 mm (mild), 1--2 mm (moderate), and more than 2 mm (severe).

VII.. Statistical analysis
--------------------------

The results of all histopathological studies were expressed as the mean ± standard deviation. Statistical analysis was performed with SofaStats 1.4.3 (Paton-Simpson & Associates, Auckland, New Zealand). Clinical data including age, sex, occurrence of hemorrhage, seizure, velocity, size of nidus, and pre-operative embolization were analyzed along with histological data. *P* values less than 0.05 were considered statistically significant.

Results
=======

In the present study, we assessed the pathological features in the BAVMs nidus particularly focusing on infiltrating cells, intimal hyperplasia, microvessels accumulation, and venous enlargement ([Fig. 1](#F1){ref-type="fig"}). Among the assessed parameters, only intimal hyperplasia and venous enlargement were predominantly affected by the clinical variables.

We identified several significant clinical variables highly influential for nidal pathology: ages, nidus diffuseness, sex, Spetzler-Martin grade, and nidal velocity ([Table 2](#T2){ref-type="table"}).

Discussion
==========

The present study revealed that intimal hyperplasia and venous enlargement in BAVMs nidus pathologically were the differentiating factors of clinical profiles of BAVMs patients. Our result might indirectly the vascular remodeling process was regulated differently between certain patients profiles. Younger age of onset and female patients tended to have the thinner intima and smaller drainer, although hemorrhage presentation was not increased in the aforementioned group, the condition might predispose for further hemorrhage if untreated. In line with this study, our previous report indicated that children and female patients had higher risk for subsequent hemorrhage after initial hemorrhage.^[@B10]^ Apparently, there is inconsistency in patients age and sex as predictors for hemorrhage in BAVMs.^[@B12],[@B13]^ It is noteworthy, racial background in the clinical series might contribute to those differences. At least, two reports from Scandinavian region also indicated that younger age^[@B7],[@B14]^ and female^[@B14]^ are more prone to future hemorrhage. Furthermore, the fertile female might get into the pregnancy thus important consideration is needed in this management of this group.^[@B15]^

In this study, angiographically obtained clinical profiles such as nidal diffuseness, velocity, and Spetzler-Martin grade were influential for the intimal hyperplasia and venous enlargement. Diffuse nidus, low flow, and higher Spetzler-Martin grade were observed to have thinner intimal hyperplasia and smaller drainer. We defined low flow BAVMs as slower transition from arterial to venous phase in angiography, this indirectly reflects the venous hypertension (Y.T. and S.M.). Those aforementioned conditions were highly consistent as hemorrhagic predictors in BAVMs.^[@B6],[@B7],[@B10]--[@B14],[@B16]^ Furthermore, in our series, higher proportion of hemorrhage presentation was obtained in low flow patients (83.3% in low flow patients, 33.3% in high flow patients). Therefore, we assumed that hemodynamic properties of BAVMs have a highly prominent role in vascular remodeling process in nidus.

To our surprise, infiltrating cells were not influenced by clinical profiles. The presence of inflammation in BAVMs nidus is well noticed,^[@B17]^ we had reported the activation of NF-kappa B and STAT3 in the BAVMs.^[@B18],[@B19]^ It is noteworthy, the precised contribution of inflammation in BAVMs pathobiology remains elusive. Moreover, our semi-quantitative scoring might also contribute to the result.

The highly angiogenic environment of BAVMs nidus is well documented, abnormality in VEGF,^[@B20],[@B21]^ Tie-2,^[@B20],[@B21]^ and HIF-1α^[@B22]^ might contribute to BAVMs pathobiology. In the present study, the highly angiogenic environment was well reflected through microvessels accumulation in the nidus; however the difference was not detectable between clinical variables. We assumed the abnormal angiogenesis is a common feature of BAVMs, thus insensitive to differentiate the high risk patients. Of note, our semi-quantitative scoring might also contribute to the result.

Conclusion
==========

In this study, the intimal hyperplasia and venous enlargement were distinctly influenced by clinical features. Younger age and female patients, as well as angiographical features of diffuse nidus, low flow, and high Spetzler-Martin grade possessed thinner intimal hyperplasia and smaller drainer. Those conditions might predispose high risk patients to higher tendency of hemorrhage in Japanese patients. Future investigation is necessary to elucidate the underlying mechanism.

![Hematoxylin-eosin staining of human brain arteriovenous malformations tissues. A: profound venous enlargement is well identified. B: Intimal hyperplasia is found in the venous wall. C: Infiltrating cells can be observed in the vascular walls and perivascular tissues. D: Microvessels accumulation with profound infiltrating cells at the enlarged and hyperplastic vein can be observed. Scale bars: 300 μm.](nmc-56-340-g1){#F1}

###### 

Summary of clinical data

  Characteristics             Frequency
  --------------------------- ------------
  Age                         
    ≥ 20 years                39 (72.2%)
    \< 20 years               15 (28.8%)
  Hemorrhage presentation     27 (50.0%)
  Location                    
    Frontal lobe              21 (38.9%)
    Parietal lobe             14 (25.9%)
    Temporal lobe             6 (11.1%)
    Occipital lobe            10 (18.5%)
    Cerebellum                3 (5.6%)
  Nidal diffuseness           
    Yes                       41 (75.9%)
    No                        13 (24.1%)
  Preoperative embolization   10 (18.5%)
  Seizure presentation        14 (25.9%)
  Sex                         
    Male                      29 (53.7%)
    Female                    26 (46.3%)
  Size of nidus               
    \< 3 cm                   27 (50.0%)
    ≥ 3 cm                    27 (50.0%)
  Spetzler-Martin grade       
    Grade I                   14 (25.9%)
    Grade II                  26 (48.1%)
    Grade III                 12 (22.2%)
    Grade IV                  1 (1.9%)
    Grade V                   1 (1.9%)
  Velocity                    
    High flow                 36 (66.7%)
    Low flow                  18 (33.3%)

###### 

Summary of statistical analysis for histopathological features

  Clinical manifestations      Histological characteristics                                                                 
  ---------------------------- ------------------------------ ----------------------------------------------- ------------- -----------------------------------------------
  Age                                                                                                                       
    ≥ 20 years                 1.95 ± 0.79                    2.56 ± 0.72[^\*^](#TFN1){ref-type="table-fn"}   2.10 ± 0.82   2.90 ± 0.38[^\*^](#TFN1){ref-type="table-fn"}
    \< 20 years                1.93 ± 0.96                    1.60 ± 0.74                                     2.27 ± 0.80   2.27 ± 0.70
  Hemorrhage presentation                                                                                                   
    Yes                        2.04 ± 0.90                    2.11 ± 0.89                                     2.33 ± 0.73   2.63 ± 0.56
    No                         1.85 ± 0.77                    2.48 ± 0.75                                     1.96 ± 0.85   2.81 ± 0.56
  Nidal diffuseness                                                                                                         
    Compact                    1.93 ± 0.82                    2.44 ± 0.78[^\*^](#TFN1){ref-type="table-fn"}   2.15 ± 0.79   2.80 ± 0.51
    Diffuse                    2.00 ± 0.91                    1.85 ± 0.90                                     2.15 ± 0.90   2.46 ± 0.66
  Pre-operative embolization                                                                                                
    Yes                        1.90 ± 0.88                    2.00 ± 0.82                                     2.00 ± 0.82   2.70 ± 0.48
    No                         1.95 ± 0.83                    2.36 ± 0.84                                     2.18 ± 0.81   2.73 ± 0.59
  Seizure presentation                                                                                                      
    Yes                        1.86 ± 0.86                    2.29 ± 0.83                                     2.00 ± 0.88   2.64 ± 0.74
    No                         1.98 ± 0.83                    2.30 ± 0.85                                     2.20 ± 0.79   2.75 ± 0.49
  Sex                                                                                                                       
    Male                       1.79 ± 0.77                    2.59 ± 0.78[^\*^](#TFN1){ref-type="table-fn"}   2.10 ± 0.82   2.86 ± 0.44
    Female                     2.12 ± 0.88                    1.96 ± 0.79                                     2.20 ± 0.82   2.56 ± 0.65
  Spetzler-Martin Grade                                                                                                     
    \< 3                       2.03 ± 0.84                    2.46 ± 0.76[^\*^](#TFN1){ref-type="table-fn"}   2.23 ± 0.81   2.79 ± 0.52
    ≥ 3                        1.77 ± 0.83                    1.77 ± 0.93                                     2.00 ± 0.82   2.46 ± 0.66
  Velocity                                                                                                                  
    High                       2.06 ± 0.83                    2.61 ± 0.60[^\*^](#TFN1){ref-type="table-fn"}   2.11 ± 0.85   2.86 ± 0.49[^\*^](#TFN1){ref-type="table-fn"}
    Low                        1.72 ± 0.83                    1.67 ± 0.91                                     2.22 ± 0.73   2.44 ± 0.62

indicates *p* \< 0.05, statistical test performed with Mann-Whitney U test.
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